NASDAQ:CYCN

Cyclerion Therapeuticsinc Stock Earnings Reports

etoro logo Buy CYCN
*Your capital is at risk
$3.00
-0.0200 (-0.662%)
At Close: Jun 03, 2026

Cyclerion TherapeuticsInc Earnings Calls

Mar 31, 2026
-$0.760 (95.58%)
Release date May 12, 2026
EPS estimate -$17.20
EPS actual -$0.760
EPS Surprise 95.58%
Revenue estimate -
Revenue actual -
Dec 31, 2025
-$0.190 (50.00%)
Release date Mar 30, 2026
EPS estimate -$0.380
EPS actual -$0.190
EPS Surprise 50.00%
Revenue estimate 100K
Revenue actual 100K
Sep 30, 2025
Release date Nov 12, 2025
EPS estimate -
EPS actual -$0.300
Revenue estimate -
Revenue actual 875K
Jun 30, 2025
Release date Aug 05, 2025
EPS estimate -
EPS actual -$0.110
Revenue estimate -
Revenue actual 93K

Last 4 Quarters for Cyclerion TherapeuticsInc

Below you can see how CYCN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jun 30, 2025
Release date Aug 05, 2025
Price on release $2.89
EPS estimate -
EPS actual -$0.110
Date Price
Jul 30, 2025 $2.64
Jul 31, 2025 $2.65
Aug 01, 2025 $2.59
Aug 04, 2025 $2.79
Aug 05, 2025 $2.89
Aug 06, 2025 $2.39
Aug 07, 2025 $2.36
Aug 08, 2025 $2.29
Aug 11, 2025 $2.17
4 days before 9.47%
4 days after -24.91%
On release day -17.30%
Change in period -17.80%
Sep 30, 2025
Release date Nov 12, 2025
Price on release $1.42
EPS estimate -
EPS actual -$0.300
Date Price
Nov 06, 2025 $1.69
Nov 07, 2025 $1.62
Nov 10, 2025 $1.80
Nov 11, 2025 $1.61
Nov 12, 2025 $1.42
Nov 13, 2025 $1.48
Nov 14, 2025 $1.41
Nov 17, 2025 $1.39
Nov 18, 2025 $1.44
4 days before -15.98%
4 days after 1.41%
On release day 4.23%
Change in period -14.79%
Dec 31, 2025 Beat
Release date Mar 30, 2026
Price on release $1.45
EPS estimate -$0.380
EPS actual -$0.190
EPS surprise 50.00%
Date Price
Mar 24, 2026 $1.64
Mar 25, 2026 $1.62
Mar 26, 2026 $1.55
Mar 27, 2026 $1.51
Mar 30, 2026 $1.45
Mar 31, 2026 $1.55
Apr 01, 2026 $6.38
Apr 02, 2026 $6.15
Apr 06, 2026 $4.15
4 days before -11.89%
4 days after 187.20%
On release day 7.27%
Change in period 153.05%
Mar 31, 2026 Beat
Release date May 12, 2026
Price on release $3.18
EPS estimate -$17.20
EPS actual -$0.760
EPS surprise 95.58%
Date Price
May 06, 2026 $3.24
May 07, 2026 $3.15
May 08, 2026 $3.10
May 11, 2026 $3.19
May 12, 2026 $3.18
May 13, 2026 $3.13
May 14, 2026 $3.09
May 15, 2026 $3.12
May 18, 2026 $3.02
4 days before -1.85%
4 days after -5.03%
On release day -1.57%
Change in period -6.79%

Cyclerion TherapeuticsInc Earnings History

Earnings Calendar

FAQ

When is the earnings report for CYCN?
Cyclerion TherapeuticsInc. (CYCN) has scheduled its earnings report for Aug 04, 2026 after the markets close.

What is the CYCN price-to-earnings (P/E) ratio?
CYCN P/E ratio as of Jun 03, 2026 (TTM) is -2.39.

What is the CYCN EPS forecast?
The forecasted EPS (Earnings Per Share) for Cyclerion TherapeuticsInc. (CYCN) for the first fiscal quarter 2026 is -$7.10.

What are Cyclerion TherapeuticsInc.'s retained earnings?
On its balance sheet, Cyclerion TherapeuticsInc. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT CYCLERION THERAPEUTICSINC.
Cyclerion TherapeuticsInc
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE